Ensign Peak Advisors
NTUS

Ensign Peak Advisors’s Natus Medical Inc NTUS Stock Holding History

Ensign Peak Advisors’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-13,487
Closed -$354K – 2243
2022
Q1 		$354K Hold
13,487
– – ﹤0.01% 1695
2021
Q4 		$320K Sell
13,487
-12,850
-49% -$317K ﹤0.01% 1795
2021
Q3 		$661K Hold
26,337
– – ﹤0.01% 1563
2021
Q2 		$684K Hold
26,337
– – ﹤0.01% 1540
2021
Q1 		$674K Hold
26,337
– – ﹤0.01% 1543
2020
Q4 		$528K Hold
26,337
– – ﹤0.01% 1593
2020
Q3 		$451K Hold
26,337
– – ﹤0.01% 1556
2020
Q2 		$575K Hold
26,337
– – ﹤0.01% 1433
2020
Q1 		$609K Hold
26,337
– – ﹤0.01% 1340
2019
Q4 		$869K Buy
+26,337
New +$844K ﹤0.01% 1384

Other funds holding NTUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
MAM
Melqart Asset Management London, United Kingdom $1.01B AUM 84.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ensign Peak Advisors's NTUS Position: Q2 2022 in Review

Ensign Peak Advisors sold out of Natus Medical Inc (NTUS) in Q2 2022, closing a stake of 13,487 shares — an estimated $354K sold.

Ensign Peak Advisors first reported a position in NTUS in Q4 2019 and held it in 10 quarters. The position peaked at $869K in Q4 2019. 186 funds tracked by Wall St. Rank hold NTUS as of Q2 2022.

  • Ensign Peak Advisors reported no remaining Natus Medical Inc position as of Q2 2022 after selling out during the quarter.
  • Ensign Peak Advisors sold 13,487 Natus Medical Inc shares in Q2 2022, an estimated $354K.
  • Ensign Peak Advisors first reported a position in Natus Medical Inc in Q4 2019 and held it in 10 quarters.
  • Ensign Peak Advisors's Natus Medical Inc position peaked at $869K in Q4 2019.
  • 186 funds tracked by Wall St. Rank held Natus Medical Inc as of Q2 2022.

Based on Ensign Peak Advisors's 13F filing for Q2 2022, filed 12 Aug 2022.